Digital Health will transform the business models of the pharmaceutical industry. Therefore, Arthur D. Little and Karlsruhe Service Research Institute (KSRI) published a study about the “Impact of Digital Health on the Pharmaceutical Industry - Will Business Models be Reshaped by Digital Health?.” On 16 pages the authors explain how Digital Health will enable pharmaceutical companies to activate new business segments as well as to significantly improve their competitive advantage. The highlighted findings show that the majority of executives and senior managers have understood the value and business potential behind Digital Health and its concepts. Successful implementation of Digital Health strategies will result in transformation across four main areas: organizational prioritization, customer focus, enlargement of capabilities and uncertainty of revenue streams. More information about study’s results you’ll find via the link above.
Digital Health: Study with Arthur D. Little
|Date:||08.01.2014||links:||PDF: Impact of Digital Health on the Pharmaceutical Industry|